# Dragonfly Energy Holdings Corp.: financial statements, quarterly

DFLI · Nasdaq · CIK 1847986 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dfli.md) · [Financials](/companies/dfli/financials.md) · [Filings](/companies/dfli/filings.md) · [Insiders](/companies/dfli/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dfli/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [15.9](/filings/0001493152-24-045922.md) | [10.4 d](/filings/0001641172-25-001755.md) | [12.5](/filings/0001641172-25-011280.md) | [13.2](/filings/0001493152-25-011982.md) | [12.7](/filings/0001493152-25-023502.md) | [12.2 d](/filings/0001493152-26-013635.md) | [13.4](/filings/0001493152-26-023103.md) | [16.2](/filings/0001493152-26-037994.md) | [16.0](/filings/0001493152-25-023502.md) | [13.1 d](/filings/0001493152-26-013635.md) | [9.7](/filings/0001493152-26-023103.md) | [13.2](/filings/0001493152-26-037994.md) |
| Cost of revenue | $m | [11.3](/filings/0001493152-24-045922.md) | [8.2 d](/filings/0001641172-25-001755.md) | [9.5](/filings/0001641172-25-011280.md) | [10.0](/filings/0001493152-25-011982.md) | [9.9](/filings/0001493152-25-023502.md) | [9.7 d](/filings/0001493152-26-013635.md) | [9.4](/filings/0001493152-26-023103.md) | [11.6](/filings/0001493152-26-037994.md) | [11.2](/filings/0001493152-25-023502.md) | [10.7 d](/filings/0001493152-26-013635.md) | [8.0](/filings/0001493152-26-023103.md) | [8.8](/filings/0001493152-26-037994.md) |
| Gross profit | $m | [4.6](/filings/0001493152-24-045922.md) | [2.3 d](/filings/0001641172-25-001755.md) | [3.1](/filings/0001641172-25-011280.md) | [3.2](/filings/0001493152-25-011982.md) | [2.9](/filings/0001493152-25-023502.md) | [2.5 d](/filings/0001493152-26-013635.md) | [3.9](/filings/0001493152-26-023103.md) | [4.6](/filings/0001493152-26-037994.md) | [4.7](/filings/0001493152-25-023502.md) | [2.4 d](/filings/0001493152-26-013635.md) | [1.7](/filings/0001493152-26-023103.md) | [4.3](/filings/0001493152-26-037994.md) |
| Research and development | $m | [1.4](/filings/0001493152-24-045922.md) | [0.5 d](/filings/0001641172-25-001755.md) | [1.3](/filings/0001641172-25-011280.md) | [1.5](/filings/0001493152-25-011982.md) | [1.6](/filings/0001493152-25-023502.md) | [1.0 d](/filings/0001493152-26-013635.md) | [1.0](/filings/0001493152-26-023103.md) | [0.7](/filings/0001493152-26-037994.md) | [0.6](/filings/0001493152-25-023502.md) | [0.7 d](/filings/0001493152-26-013635.md) | [1.0](/filings/0001493152-26-023103.md) | [0.6](/filings/0001493152-26-037994.md) |
| Operating income | $m | [(5.9)](/filings/0001493152-24-045922.md) | [(3.1) d](/filings/0001641172-25-001755.md) | [(5.8)](/filings/0001641172-25-011280.md) | [(6.7)](/filings/0001493152-25-011982.md) | [(6.0)](/filings/0001493152-25-023502.md) | [(7.1) d](/filings/0001493152-26-013635.md) | [(5.9)](/filings/0001493152-26-023103.md) | [(3.3)](/filings/0001493152-26-037994.md) | [(3.8)](/filings/0001493152-25-023502.md) | [(10.2) d](/filings/0001493152-26-013635.md) | [(5.7)](/filings/0001493152-26-023103.md) | [(2.9)](/filings/0001493152-26-037994.md) |
| Interest expense | $m | [(4.0)](/filings/0001493152-24-045922.md) | [28.0 d](/filings/0001493152-24-014831.md) | [4.8](/filings/0001493152-24-019360.md) | [4.9](/filings/0001493152-25-011982.md) | [5.6](/filings/0001493152-25-023502.md) | [6.3 d](/filings/0001493152-26-013635.md) | [4.7](/filings/0001493152-26-023103.md) | [5.4](/filings/0001493152-26-037994.md) | [6.4](/filings/0001493152-25-023502.md) | [3.7 d](/filings/0001493152-26-013635.md) | [1.5](/filings/0001493152-26-023103.md) | [1.5](/filings/0001493152-26-037994.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(10.0)](/filings/0001493152-24-045922.md) | [3.3 d](/filings/0001641172-25-001755.md) | [(10.4)](/filings/0001493152-25-023502.md) | [(13.6)](/filings/0001493152-25-023502.md) | [(6.8)](/filings/0001493152-25-023502.md) | [(9.8) d](/filings/0001493152-26-013635.md) | [(6.8)](/filings/0001493152-26-037994.md) | [(7.0)](/filings/0001493152-26-037994.md) | [(11.1)](/filings/0001493152-25-023502.md) | [(45.0) d](/filings/0001493152-26-013635.md) | [(6.6)](/filings/0001493152-26-037994.md) | [(4.4)](/filings/0001493152-26-037994.md) |
| Diluted EPS | $ per share | [(0.17)](/filings/0001493152-24-045922.md) | not reported | [(1.55)](/filings/0001641172-25-011280.md) | [(2.02)](/filings/0001493152-25-011982.md) | [(0.98)](/filings/0001493152-25-023502.md) | not reported | [(9.28)](/filings/0001493152-26-023103.md) | [(5.77)](/filings/0001493152-26-037994.md) | [(0.20)](/filings/0001493152-25-023502.md) | not reported | [(0.64)](/filings/0001493152-26-023103.md) | [(0.43)](/filings/0001493152-26-037994.md) |
| Basic EPS | $ per share | [(0.17)](/filings/0001493152-24-045922.md) | not reported | [(1.55)](/filings/0001641172-25-011280.md) | [(2.02)](/filings/0001493152-25-011982.md) | [(0.98)](/filings/0001493152-25-023502.md) | not reported | [(9.28)](/filings/0001493152-26-023103.md) | [(5.77)](/filings/0001493152-26-037994.md) | [(0.20)](/filings/0001493152-25-023502.md) | not reported | [(0.64)](/filings/0001493152-26-023103.md) | [(0.43)](/filings/0001493152-26-037994.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | period not labelled (2025-02-28) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.7](/filings/0001641172-25-001755.md) | [8.5](/filings/0001493152-24-019360.md) | [4.7](/filings/0001493152-24-032322.md) | [8.0](/filings/0001493152-24-045922.md) | [4.8](/filings/0001493152-26-013635.md) | [2.5](/filings/0001493152-25-011982.md) | [2.8](/filings/0001641172-25-011280.md) | [2.7](/filings/0001493152-25-011982.md) | [3.8](/filings/0001493152-25-023502.md) | [18.3](/filings/0001493152-26-037994.md) | [8.6](/filings/0001493152-26-023103.md) | [6.3](/filings/0001493152-26-037994.md) |
| Current assets | $m | [55.9](/filings/0001641172-25-001755.md) | [47.7](/filings/0001493152-24-019360.md) | [40.1](/filings/0001493152-24-032322.md) | [39.3](/filings/0001493152-24-045922.md) | [32.9](/filings/0001493152-26-013635.md) | not reported | [33.4](/filings/0001641172-25-011280.md) | [30.8](/filings/0001493152-25-011982.md) | [34.5](/filings/0001493152-25-023502.md) | [50.2](/filings/0001493152-26-037994.md) | [40.0](/filings/0001493152-26-023103.md) | [34.8](/filings/0001493152-26-037994.md) |
| Total assets | $m | [75.2](/filings/0001641172-25-001755.md) | [88.4](/filings/0001493152-24-019360.md) | [85.0](/filings/0001493152-24-032322.md) | [83.9](/filings/0001493152-24-045922.md) | [75.2](/filings/0001493152-26-013635.md) | not reported | [74.2](/filings/0001641172-25-011280.md) | [71.8](/filings/0001493152-25-011982.md) | [73.8](/filings/0001493152-25-023502.md) | [86.5](/filings/0001493152-26-037994.md) | [75.7](/filings/0001493152-26-023103.md) | [70.3](/filings/0001493152-26-037994.md) |
| Current liabilities | $m | [40.4](/filings/0001641172-25-001755.md) | [43.5](/filings/0001493152-24-019360.md) | [44.6](/filings/0001493152-24-032322.md) | [49.3](/filings/0001493152-24-045922.md) | [21.9](/filings/0001493152-26-013635.md) | not reported | [24.4](/filings/0001641172-25-011280.md) | [22.4](/filings/0001493152-25-011982.md) | [25.7](/filings/0001493152-25-023502.md) | [19.8](/filings/0001493152-26-037994.md) | [16.6](/filings/0001493152-26-023103.md) | [14.9](/filings/0001493152-26-037994.md) |
| Total liabilities | $m | [47.3](/filings/0001641172-25-001755.md) | [70.6](/filings/0001493152-24-019360.md) | [79.7](/filings/0001493152-24-032322.md) | [84.2](/filings/0001493152-24-045922.md) | [84.6](/filings/0001493152-26-013635.md) | not reported | [87.0](/filings/0001641172-25-011280.md) | [87.1](/filings/0001493152-25-011982.md) | [95.4](/filings/0001493152-25-023502.md) | [52.8](/filings/0001493152-26-037994.md) | [48.9](/filings/0001493152-26-023103.md) | [47.0](/filings/0001493152-26-037994.md) |
| Long-term debt | $m | [75.9](/filings/0001493152-24-014831.md) | [77.1](/filings/0001493152-24-019360.md) | [80.4](/filings/0001493152-24-032322.md) | [82.4](/filings/0001493152-24-045922.md) | [29.6](/filings/0001641172-25-001755.md) | not reported | [33.6](/filings/0001641172-25-011280.md) | [38.6](/filings/0001493152-25-011982.md) | [44.5](/filings/0001493152-25-023502.md) | [9.2](/filings/0001493152-26-013635.md) | [9.9](/filings/0001493152-26-023103.md) | [10.6](/filings/0001493152-26-037994.md) |
| Current portion of debt | $m | [19.7](/filings/0001493152-24-014831.md) | [21.8](/filings/0001493152-24-019360.md) | [21.9](/filings/0001493152-24-032322.md) | [24.4](/filings/0001493152-24-045922.md) | not reported | not reported | not reported | [0.4](/filings/0001493152-25-011982.md) | [0.9](/filings/0001493152-25-023502.md) | [0.4](/filings/0001493152-26-013635.md) | [0.5](/filings/0001493152-26-023103.md) | [0.5](/filings/0001493152-26-037994.md) |
| Shareholders' equity | $m | [27.9](/filings/0001493152-26-013635.md) | [17.8](/filings/0001493152-25-023502.md) | [5.3](/filings/0001493152-25-023502.md) | [(0.3)](/filings/0001493152-25-023502.md) | [(9.4)](/filings/0001493152-26-037994.md) | not reported | [(15.6)](/filings/0001493152-26-037994.md) | [(16.6)](/filings/0001493152-26-037994.md) | [(21.6)](/filings/0001493152-25-023502.md) | [11.5](/filings/0001493152-26-037994.md) | [3.9](/filings/0001493152-26-037994.md) | [(0.2)](/filings/0001493152-26-037994.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(11.1) d](/filings/0001493152-24-045922.md) | [(1.0) d](/filings/0001641172-25-001755.md) | [(3.4)](/filings/0001641172-25-011280.md) | [(4.0) d](/filings/0001493152-25-011982.md) | [2.7 d](/filings/0001493152-25-023502.md) | [(2.5) d](/filings/0001493152-26-013635.md) | [(4.5)](/filings/0001493152-26-023103.md) | [(3.4) d](/filings/0001493152-26-037994.md) | [(3.4) d](/filings/0001493152-25-023502.md) | [(14.7) d](/filings/0001493152-26-013635.md) | [(8.8)](/filings/0001493152-26-023103.md) | [(1.9) d](/filings/0001493152-26-037994.md) |
| Capital expenditure | $m | [3.9 d](/filings/0001493152-24-045922.md) | [0.4 d](/filings/0001641172-25-001755.md) | [0.8](/filings/0001641172-25-011280.md) | [0.5 d](/filings/0001493152-25-011982.md) | [0.4 d](/filings/0001493152-25-023502.md) | [1.0 d](/filings/0001493152-26-013635.md) | [0.8](/filings/0001493152-26-023103.md) | [0.8 d](/filings/0001493152-26-037994.md) | [0.2 d](/filings/0001493152-25-023502.md) | [0.1 d](/filings/0001493152-26-013635.md) | [0.3](/filings/0001493152-26-023103.md) | [0.4 d](/filings/0001493152-26-037994.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [38.1](/filings/0001493152-23-041072.md) | [48.5](/filings/0001493152-24-019360.md) | [47.4](/filings/0001493152-24-032322.md) | [58.7](/filings/0001493152-24-045922.md) | [6.7](/filings/0001641172-25-011280.md) | [6.7](/filings/0001493152-25-011982.md) | [6.9](/filings/0001493152-25-023502.md) | [0.7](/filings/0001493152-26-023103.md) | [1.2](/filings/0001493152-26-037994.md) | [56.2](/filings/0001493152-25-023502.md) | [12.1](/filings/0001493152-26-023103.md) | [12.7](/filings/0001493152-26-037994.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,978,803 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-037994.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.